• Systematic approach in the field of vascular anomalies;

  • A large sample set as bases for the development of the project ;

  •  A set of highly relevant and new in vitro and in vivo models;

  •  Comprehensive approach to cover the discovery line from patients to drug identification and pre-clinical testing;

  •  Unique ITN network and collaboration;

  • Widely experienced future scientists with the hands on expertise in industry and academia.